Get started
Author

Mariya Borisovna Borgoyakova

Observed names: M B Borgoyakova, M. B. Borgoyakova, M. V. Borgoyakova, M.B. Borgoyakova, Maria B. Borgoyakova, Maria B. Borgoyakova, Maria Borisovna Borgoyakova, Mariya B. Borgoyakova, Боргоякова М. Б., Боргоякова Мария Борисовна, М. Б. Боргоякова, М.Б. Боргоякова
ORCID: 0000-0002-0768-1561
Observed ORCID: 0000-0002-0768-1561
OpenAlex ID: A5067120339
Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems
2022 · Iuliia A. Merkuleva, Dmitry N. Shcherbakov, et al. · Vaccines · 41
PDF
Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate
2021 · Larisa I. Karpenko, Andrey P. Rudometov, et al. · Vaccines · 40
PDF
Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens
2021 · Ekaterina V. Starostina, Sergei V. Sharabrin, et al. · Vaccines · 29
PDF
Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice
2022 · Mariya B. Borgoyakova, Larisa I. Karpenko, et al. · International Journal of Molecular Sciences · 28
PDF
Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
2021 · M. B. Borgoyakova, L. I. Karpenko, et al. · Molecular Biology · 23
PDF
Comparison of the Effectiveness of Transepidemal and Intradermal Immunization of Mice with the Vacinia Virus
2023 · Sergei N. Shchelkunov, Aleksander A. Sergeev, et al. · Acta Naturae · 19
PDF
Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
2022 · Iuliia A. Merkuleva, Dmitry N. Shcherbakov, et al. · Viruses · 16
PDF
Optimization of In Vivo Electroporation Conditions and Delivery of DNA Vaccine Encoding SARS-CoV-2 RBD Using the Determined Protocol
2022 · Denis Nikolaevich Kisakov, Lyubov Alexandrovna Kisakova, et al. · Pharmaceutics · 13
PDF
Immunogenic and Protective Properties of Recombinant Hemagglutinin of Influenza A (H5N8) Virus
2024 · Nadezhda B. Rudometova, Anastasia A. Fando, et al. · Vaccines · 11
PDF
Immunogenic and Protective Properties of mRNA Vaccine Encoding Hemagglutinin of Avian Influenza A/H5N8 Virus, Delivered by Lipid Nanoparticles and Needle-Free Jet Injection
2025 · Vladimir A. Yakovlev, Victoria R. Litvinova, et al. · Vaccines · 9
PDF
DNA Vaccine Encoding a Modified Hemagglutinin Trimer of Avian Influenza A Virus H5N8 Protects Mice from Viral Challenge
2024 · Victoria R. Litvinova, Andrey P. Rudometov, et al. · Vaccines · 9
Enhancing the Immunogenicity of Vaccinia Virus
2022 · Sergei N. Shchelkunov, Stanislav N. Yakubitskiy, et al. · Viruses · 9
PDF
Adaptive Immune Response to Vaccinia Virus LIVP Infection of BALB/c Mice and Protection against Lethal Reinfection with Cowpox Virus
2021 · Sergei N. Shchelkunov, Alexander A. Sergeev, et al. · Viruses · 9
PDF
Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice
2025 · Denis N. Kisakov, Larisa I. Karpenko, et al. · Vaccines · 7
PDF
Delivery of Experimental mRNA Vaccine Encoding the RBD of SARS-CoV-2 by Jet Injection
2024 · D. N. Kisakov, L. A. Kisakova, et al. · Bulletin of Experimental Biology and Medicine · 7
Dose-Dependent Effect of DNA Vaccine pVAX-H5 Encoding a Modified Hemagglutinin of Influenza A (H5N8) and Its Cross-Reactivity Against A (H5N1) Influenza Viruses of Clade 2.3.4.4b
2025 · Andrey P. Rudometov, Victoria R. Litvinova, et al. · Viruses · 6
Needle-Free Jet-Delivered mRNA-Vaccine Encoding Influenza A(H1N1)pdm09 Hemagglutinin Protects Mice from Lethal Virus Infection
2025 · S. V. Sharabrin, A. A. Ilyichev, et al. · Molecular Biology · 5
Artificial COVID-19 T-Cell Immunogen
2023 · M. B. Borgoyakova, L. I. Karpenko, et al. · Bulletin of Experimental Biology and Medicine · 5
An Attenuated and Highly Immunogenic Variant of the Vaccinia Virus
2024 · S. N. Shchelkunov, S. N. Yakubitskiy, et al. · Acta Naturae · 4
Immunogenicity and Protective Efficacy of a Single Intranasal Dose Vectored Vaccine Based on Sendai Virus (Moscow Strain) against SARS-CoV-2 Variant of Concern
2024 · Galina V. Kochneva, Gleb A. Kudrov, et al. · Vaccines · 4
Artificial COVID-19 T-cell immunogen
2023 · M. B. Borgoyakova, L. I. Karpenko, et al. · Bulletin of Experimental Biology and Medicine · 4
A Naked Lyophilized mRNA Vaccine Against Seasonal Influenza, Administered by Jet Injection, Provides a Robust Response in Immunized Mice
2026 · Sergei V. Sharabrin, Svetlana I. Krasnikova, et al. · Vaccines · 3
PDF
Development of a vaccine adjuvant based on squalene and study of its adjuvant properties
2023 · E. A. Volosnikova, D. N. Shcherbakov, et al. · Medical Immunology (Russia) · 3
PDF
Use of Adjuvant Compositions Based on Squalene Ensures Induction of Neutralizing Antibodies against SARS-CoV-2
2024 · E. A. Volosnikova, N. V. Volkova, et al. · Bulletin of Experimental Biology and Medicine · 2
DNA Vaccine Encoding the Artificial T-Cell Polyepitope Immunogen of Tick-Borne Encephalitis Virus
2023 · D. N. Kisakov, D. V. Antonets, et al. · Bulletin of Experimental Biology and Medicine · 2
Works count: 79
Citation count: 324
H-index: 9
I10-index: 9
Year
Topic
Type